PUBLIC COMPANY
saveGENZYME
USupdated 6mo ago
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Al Sandrock to step down as Voyager CEO; Insmed adds Paul Hudson to board→ Al Sandrock is calling it quits as CEO of Voyager Therapeutics in the first quarter next year, but he will stay on the board. Chief business and operating officer Robin Swartz, a Sanofi Genzyme ...endpoints · 17d ago
- Novartis’ Rhapsido cuts MS progression in Phase 3 trial, teeing up Roche battleNovartis is planning to file for remibrutinib’s expanded approval in relapsing multiple sclerosis by next year, putting it just behind Roche's own BTK inhibitor fenebrutinib.biospace · 2mo ago
- Chutes & Ladders—Neumora shuffles leadership ahead of INDJoshua Pinto, Ph.D., has been appointed chief executive officer of Neumora Therapeutics, a clinical-stage biotech with obesity and neuro assets.fiercebiotech · 2mo ago
- FDA warns Genzyme's Irish site over quality questionsAn FDA warning letter sent late last month to Genzyme's Ireland-based manufacturing site, now owned by Sanofi, raises significant quality- and data-related issues. On data integrity, the warning le…endpoints · 4mo ago
comments(0)
5-min edit window · permanent after that